Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models

BACKGROUND & OBJECTIVES: Alteration in the serotonin leads to the psychological illness, such as depression, anxiety, schizophrenia, eating disorders, obsessive-compulsive disorder, panic disorders and migraines. The objective of the current study was to investigate the antidepressant and anxiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Dilip Kumar, Devadoss, Thangraj, Modak, Neha, Mahesh, Radhakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345311/
https://www.ncbi.nlm.nih.gov/pubmed/28256473
http://dx.doi.org/10.4103/0971-5916.200893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345311/
https://www.ncbi.nlm.nih.gov/pubmed/28256473
http://dx.doi.org/10.4103/0971-5916.200893

Ejemplares similares